Skip to main content

Table 5 The outcome of patients with GTN

From: Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study

Group of patients with GTN

Time to GTN diagnosis (day)

No. of courses of chemotherapy to cure

Chemotherapy resistance

Time for hCG to remission (day)

Follow-up

Group I (n = 46)

54.0 ± 38.5

3.2 ± 1.9

23.7%(9/38)

59.6 ± 26.4

46 remission, 1 recurred 4 years later and died of brain metastasis

Group II (n = 5)

94.6 ± 35.9*

4.2 ± 2.4

80.0%(4/5)**

60.4 ± 18.6

5 remission,0 death

Group III (n = 4)

60.7 ± 43.0

2.7 ± 1.5

25.0%(1/4)

52.0 ± 23.3

4 remission,0 death

  1. * P = 0.031, compared to Group I; ** P = 0.024 compared to Group I
  2. Risk factors such as pre-evacuation hCG level, a theca luteal cyst over 6 cm and an enlarged uterus over presentation date and prognostic scores were evaluated among groups and no statistically significances were found